Impact of Pots-stroke Depression Treatment on Stroke Recurrence
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,230
- 试验地点
- 1
- 主要终点
- Stroke recurrence
研究概览
简要总结
It is not clear whether depresssion can predispose, or precipitate stroke recurrence in patients with stroke. We sought the relationship of post stroke depression with stroke recurrence.
详细描述
A large body of evidence suggests that depression is associated with a increased risk of many chronic diseases, including hypertension, diabetes, stroke and particularly coronary heart disease. Post stroke depression (PSD) may develop as a result of vascular disease. A previous meta-analysis showed that depression significantly increased the risk of development of stroke, and this increase was probably independent of other risk factors, including hypertension and diabetes.
Clarifying this issue has important implications; if depression increases the risk of development of recurrent stroke, so treating PSD might decrease the occurrence of recurrent stroke. To our knowledge there is no study attempting to clarify the relationship between PSD treatment and stroke recurrence. To fill these gap, we systematically conducted a study to assess whether PSD is associated with recurrent stroke, cardiovascular events or death. Thus, in the current study, three different arms of follow-up of patients with first-ever stroke, were used to predict the outcome over 52 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Single (Outcomes Assessor)
盲法说明
There is no masking
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who met DSM-IV and V criteria for depression
排除标准
- •Severe or unstable medical disorders (eg, myocardial infarction within past 3 months, end-stage cancer, decompensated cardiac failure)
- •Known primary neurological disorders including dementia, delirium, Parkinson disease, brain tumors, multiple sclerosis, seizure disorder
- •Drugs (eg, systemic steroids)
- •Pancreatic cancer, uncorrected hypothyroidism
- •Current suicidal risk
- •Use of psychotropic prescription or nonprescription drugs, certain hypnotics
- •Mini-Mental State Examination (MMSE) score of 21 or lower
研究组 & 干预措施
Depressive patients with treatment
This group included patients wit depression but with treatment during enrollment of the cases.
干预措施: Citalopram (Drug)
结局指标
主要结局
Stroke recurrence
时间窗: 12 months
Standard World Health Organization definitions were used for recurrent stroke
次要结局
- Cardiovascular Event(12 months)
研究者
Prof. Dr. Emre Kumral
Prof. Dr. MD
Ege University
